Found 6 matching trials
Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC
PHASE1The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Location
Honor Health Research Institute
Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers
PHASE1This is a Phase I/Ib study in which the safety of the combination therapy o...
Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
PHASE1The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Location
Honor Health Research Institute
Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced Malignancies
PHASE1Primary Objectives:
* Part 1
* To characterize the safety and tolerability...
Location
University of California Irvine Medical Center- Site Number : 8400002
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
PHASE1To evaluate the safety and tolerability of sotorasib administered in invest...
Status
Active Not Recruiting
Location
Arizona Oncology Associates Professional Corporation
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
PHASE2The purpose of this study is to evaluate the antitumor effects of sotorasib...
Location
Florida Cancer Specialists